PATENT CLAIM ANALYSIS

Application Number: 16255769
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "139100"]

Abstract:
Disclosed herein are antibodies specific to a delta1 chain of a γδ T cell receptor and methods of using such for modulating γδ T cell bioactivity. Such anti-Delta1 antibodies may also be used to treat diseases associated with γδ T cell activation, such as solid tumors, or for detecting presence of γδ1 T cells.

Claim (Index 6):
The isolated antibody of  claim 5 , wherein the V H  comprises SEQ ID NO:23 and the V L  comprises SEQ ID NO:24.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.38095
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16173970', '15271861', '16175453', '15034782', '15712010']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7915297686533588
- 35 USC 102 Novelty (BERT): 0.5536372821424065
- Combined Prediction Score: 0.7677405200022636
- Mean Citation Score: 435.944402
- Max Citation Score: 467.11746
- Similarity Product: 289.56003829335447

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test